BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 9, 2000
View Archived Issues
Update on worldwide phase III trials of Maxamine
Read More
PDL highlights product pipeline at New York City healthcare conference
Read More
Forbes Medi-Tech's FM-VP4 inhibits cholesterol absorption in preclinical trials
Read More
Corixa outlines significant Q3 developments
Read More
Boston Life Sciences' O-1369 shows promise for PD
Read More
Questcor receives continued funding for program in neuroprotection
Read More
Abgenix acquires ImmGenics
Read More
Connetics' foam formulation for scalp dermatoses launched in U.S.
Read More
Human antibody agreement signed by Medarex and Lilly
Read More
Dyax and Bracco form diagnostic imaging alliance
Read More
Company Profile: Achillion
Read More
First phase III trial of HspE7 commences in anal dysplasia
Read More
Toxicity and pharmacokinetics of new camptothecin analogue CKD-602 determined in phase I trial
Read More
NCI-EORTC-AACR news: dual topoisomerase I/II inhibitors promising as solid tumor therapy
Read More
Clinical pharmacokinetics and toxicity of NX-211 characterized at major cancer meeting
Read More
Novel neuroprotective aminoindan undergoes extensive preclinical testing at Teva
Read More
First potent and selective, nonpeptide thrombin receptor antagonists described by Schering-Plough
Read More
Synthesis and use of new NK1 antagonists reported by AstraZeneca
Read More
PC-PLD inhibitors preferentially abrogate growth and proliferation of tumor cell lines
Read More
Novel compounds interacting with metabotropic glutamate receptors discovered at Roche
Read More
Antibacterial agents in the British Biotech pipeline
Read More
Sanofi-Synthelabo presents new therapeutics for CNS and GI disorders
Read More
Recently issued international patent covers Sanofi-Synthelabo's new NK1 ligands
Read More
French lab discloses new series with high affinity for D3 receptors
Read More
Modulators of chemokine CCR receptors claimed in patent literature by AstraZeneca
Read More
Potential new treatments for bone and cartilage disorders revealed by SB scientists
Read More
Pfizer patents fructose-lowering sorbitol dehydrogenase inhibitors
Read More
New class of tubulin polymerization inhibitors presented in Amsterdam
Read More
Addition of oprelvekin allows completion of full-dose therapy for hepatitis C
Read More